|Generate QR code
Open Access
Subscription Access
Acquired non-Wilsonian hepatocerebral degeneration
I. V. Litvinenko,
P. S. Dynin,
A. V. Ruban,
A. Yu. Emelin,
I. V. Krasakov,
V. Yu. Lobzin,
E. I. Shermatyuk,
Yu. A. Kotova,
N. V. Tsygan,
M. M. Odinak https://doi.org/10.30629/2658-7947-2025-30-1-34-39
Abstract
Objective: analysis of clinical features of non-Wilsonian hepatocerebral degeneration.
Material and methods: a systematization and analysis of data from domestic and foreign literature on the pathogenesis, clinical picture, diagnosis and treatment of a rare variant of chronic encephalopathy against the background of metabolic disorders — non-Wilsonian hepatocerebral degeneration were carried out.
Results. Our own clinical observation is presented. The main aspects of pathogenesis and risk factors are listed. The conditions and diseases that require differential diagnostics in case of suspected hepatocerebral degeneration are systematized: Wilson-Konovalov disease, non-Wilsonian hepatocerebral degeneration associated with nitrogenous base metabolism disorder, chronic manganese intoxication.
Conclusion. Due to the rare occurrence and non-specific clinical manifestations, the availability of information on the pathogenesis, clinical picture, differential diagnostics and treatment of hepatocerebral degeneration of various etiologies remains low. Improvement of the differentiated choice of diagnostic methods by a specialist, in particular magnetic resonance imaging, laboratory methods for assessing metabolic disorders, as well as gene diagnostics options contribute to the improvement of detection and differentiation of these conditions.
About the Authors
I. V. Litvinenko
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
P. S. Dynin
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
A. V. Ruban
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
A. Yu. Emelin
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
I. V. Krasakov
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
V. Yu. Lobzin
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
E. I. Shermatyuk
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
Yu. A. Kotova
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
N. V. Tsygan
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
M. M. Odinak
Military Medical Academy
Russian Federation
Russian Federation
St. Petersburg
References
1. Shin H.W., Park H.K. Recent Updates on Acquired Hepatocerebral Degeneration. Tremor Other Hyperkinet Mov (N Y). 2017 Sep 5;7:463. doi: 10.7916/D8TB1K44. PMID: 28975044.PMCID: PMC5623760.
2. Mehkari Z., Mohammed L., Javed M., Althwanay A., Ahsan F., Oliveri F., Goud H.K., Rutkofsky I.H. Manganese, a Likely Cause of ‘Parkinson’s in Cirrhosis’, a Unique Clinical Entity of Acquired Hepatocerebral Degeneration. Cureus. 2020 Sep 14;12(9):e10448. doi: 10.7759/cureus.10448. PMID: 33072457; PMCID: PMC7557798.
3. Farina M., Avila D.S., da Rocha J.B., Aschner M. Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int. 2013 Apr;62(5):575–94. doi: 10.1016/j.neuint.2012.12.006. Epub 2012 Dec 21. PMID: 23266600; PMCID: PMC3615063.
4. Taylor C.A., Hutchens S., Liu C., Jursa T., Shawlot W., Aschner M., Smith D.R., Mukhopadhyay S. SLC30A10 transporter in the digestive system regulates brain manganese under basal conditions while brain SLC30A10 protects against neurotoxicity. J Biol Chem. 2019 Feb 8;294(6):1860–1876. doi: 10.1074/jbc.RA118.005628. Epub 2018 Dec 17. PMID: 30559290; PMCID: PMC6369308.
5. Lin W., Vann D.R., Doulias P.T., Wang T., Landesberg G., Li X., Ricciotti E., Scalia R., He M., Hand N.J., Rader D.J. Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity. J Clin Invest. 2017 Jun 1;127(6):2407–2417. doi: 10.1172/JCI90896. Epub 2017 May 8. PMID: 28481222; PMCID: PMC5451243.
6. Finlayson M.H., Superville B. Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain. 1981 Mar;104(Pt 1):79–95. doi: 10.1093/brain/104.1.79. PMID: 7470846.
7. Bosoi C.R., Zwingmann C., Marin H., Parent-Robitaille C., Huynh J., Tremblay M., Rose C.F. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J Hepatol. 2014 Mar;60(3):554–60. doi: 10.1016/j.jhep.2013.10.011. Epub 2013 Oct 26. PMID: 24512824.
8. Rangroo Thrane V., Thrane A.S., Wang F., Cotrina M.L., Smith N.A., Chen M., Xu Q., Kang N., Fujita T., Nagelhus E.A., Nedergaard M. Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buff ering. Nat Med. 2013 Dec;19(12):1643–1648. doi: 10.1038/nm.3400. Epub 2013 Nov 17. PMID: 24240184; PMCID: PMC3899396.
9. Shaik I.H., Miah M.K., Bickel U., Mehvar R. Eff ects of shortterm portacaval anastomosis on the peripheral and brain disposition of the blood-brain barrier permeability marker sodium fluorescein in rats. Brain Res. 2013 Sep 19;1531:84–93. doi: 10.1016/j.brainres.2013.07.040. Epub 2013 Jul 31. PMID: 23916670.
10. Jog M.S., Lang A.E. Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord. 1995 Nov;10(6):714–22. doi: 10.1002/mds.870100604. PMID: 8749990.
11. Mendez M.F. Hepatic dementia or acquired hepatocerebral degeneration. J Am Geriatr Soc. 1989 Mar;37(3):259–260. doi: 10.1111/j.1532-5415.1989.tb06817.x. PMID: 2918197.
12. Dasarathy S., Mookerjee R.P., Rackayova V., Rangroo Thrane V., Vairappan B, Ott P, Rose CF. Ammonia toxicity: from head to toe? Metab Brain Dis. 2017 Apr;32(2):529–538. doi: 10.1007/s11011-016-9938-3. Epub 2016 Dec 24. PMID: 28012068; PMCID: PMC8839071.
13. Meissner W., Tison F. Acquired hepatocerebral degeneration. Handb Clin Neurol. 2011;100:193–197. doi: 10.1016/B978-0-444-52014-2.00011-2. PMID: 21496578.
14. Tappakhov A.A., Govorova T.G., Khabarova Yu.I., Adamova A.E., Popova T.E. Acquired (non-Wilson’s) hepatocerebral degeneration: two clinical cases of a rare disease. Trudnyj pacient = Diffi - cult Patient. 2021;19(5):48–53. (In Russ.). doi: 10.224412/2074-1005-2021-5-48-53.
15. Salehi S.D., Shawcross D.L. Reversal of acquired hepatocerebral degeneration with living donor liver transplantation. Liver Transpl. 2016 May;22(5):693. doi: 10.1002/lt.24423. PMID: 26919380.
16. Pinarbasi B., Kaymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., Ozdil S., Boztas G., Cakaloglu Y., Mungan Z., Okten A. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol. 2009 Feb;43(2):176–81. doi: 10.1097/MCG.0b013e318150d399. PMID: 18698265.
17. Poleshchuk V.V., Yakovenko E.V., Fedotova E.Yu., Illarioshkin S.N. Acquired non-Wilson’s hepatocerebral degeneration. Nervnye bolezni = Nervous Diseases. 2019;1:34–39. (In Russ.). doi: 10.24411/2071-5315-2018-12077.
Review
For citations:
Litvinenko I.V., Dynin P.S., Ruban A.V., Emelin A.Yu., Krasakov I.V., Lobzin V.Yu., Shermatyuk E.I., Kotova Yu.A., Tsygan N.V., Odinak M.M. Acquired non-Wilsonian hepatocerebral degeneration. Russian neurological journal. 2025;30(1):34-39. (In Russ.) https://doi.org/10.30629/2658-7947-2025-30-1-34-39
Views:
67
Email this article 